Surmodics | SRDX - Current Assets


Surmodics reported $81.3M in Current Assets for its fiscal quarter ending in September of 2024.





Current Assets Change Date
Abbott USD 26B 1.16B Dec/2025
Align Technology USD 2.62B 82.47M Dec/2025
Anika Therapeutics USD 101.59M 2.27M Sep/2025
Arrowhead Research USD 1.17B 223.75M Dec/2025
Artivion USD 337.5M 18.68M Sep/2025
Baxter International USD 6.87B 61M Dec/2025
Boston Scientific USD 8.79B 759M Dec/2025
EDAP TMS EUR 44.35M 7.13M Sep/2025
Edwards Lifesciences USD 6.36B 218.3M Sep/2025
Haemonetics USD 943.67M 43.99M Dec/2025
Heron Therapeutics USD 229.4M 18.48M Sep/2025
J&J USD 55.62B 1.01B Dec/2025
Merit Medical Systems USD 1.04B 54.62M Dec/2025
Mesa Laboratories USD 105.63M 8.2M Dec/2025
Nektar Therapeutics USD 281.36M 94.79M Sep/2025
Option Care Health USD 1.26B 17.8M Dec/2025
Stryker USD 14.76B 1.04B Dec/2025
Surmodics USD 81.3M 948K Sep/2024
Trinity Biotech USD 35.52M 2.52M Sep/2025